GetPortalImpactFactorByIdResp(projectId=1, id=88f62696, cover=https://img.medsci.cn/images/journal/cover/2021/jOq_202109271315111650.jpg, fullname=HEMATOLOGICAL ONCOLOGY, abbr=HEMATOL ONCOL, pyear=1983, frequence=Quarterly, articleNumbers=702, citedSelf2015=6.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0278-0232, greenSci=https://www.greensci.net/search?kw=0278-0232, scijournal=https://www.scijournal.org/impact-factor-of-HEMATOL-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=5.596, medsciHotlight=7.772, medsciHotlight5year=4.53301, citescore=4.2, hIndex=44, impactFactor=3.3, orgnization=John Wiley and Sons Ltd, orgnizationUrl=http://onlinelibrary.wiley.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1069, websiteHits=7264, guideForAuthor=null, guideForAuthorHits=47, submitWebsite=https://mc.manuscriptcentral.com/hon, submitWebsiteHits=2898, content=Hematological Oncology will consider for publication articles dealing with experimental and clinical aspects of malignant diseases of the hemopoietic and lymphoid systems. Manuscripts dealing with the following areas are invited: Acute and chronic leukemias Malignant lymphomas Allogeneic and autologous stem cell transplantation Hematopoiesis and lymphopoiesis Cytokines Epidemiology Pathology Molecular biology Molecular genetics Cytogenetics, totalCites=2319, brief=HEMATOL ONCOL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=血液学" >血液学</a></strong>”子行业的偏低级别杂志, articleType=论著为主，其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=HEMATOL ONCOL杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//m.sandwebs.com/sci/submit.do?id=88f62696'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=2), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=2)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.44), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.45), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.7), GetImpactFactorCiteScoreListResponse(year=2023, citescore=4.2)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.106), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=5.367), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=8.702), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=4.785), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=5.596)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Hematology , rank=66/122), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=213/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=158/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=HEMATOLOGY, rank=Q3), GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0278-0232[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=HEMATOLOGICAL ONCOLOGY[ta], article_number=123, article_number_cn=30, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)